Oleksiejczuk suspended by USADA one year for clomiphene
Polish light heavyweight Michal Oleksiejczuk entered the UFC on a nine-fight win streak, and won his debut, defeating Khalil Rountree at UFC 219 in Las Vegas, Nevada, on December 12, 2017. It was a tremendously promising start, but Oleksiejczuk failed an anti-doping test, for clomiphene.
in March the Nevada State Athletic Commission delivered a stern response:
•Bout was changed from a win to a No Contest;
•One year suspension, ending December 30;
•30% of $12,000 show money, or $3600; and,
•Relicensing will require clean drug tests.
Now USADA, which administers the UFC Anti-Doping Program, has also announced sanction. Via UFC.USADA.org.
Michał Oleksiejczuk, of Cycow, Poland, has accepted a one-year sanction for a violation of the UFC Anti-Doping Policy after testing positive for a prohibited substance.
Oleksiejczuk, 23, tested positive for clomiphene following an in-competition urine test conducted on December 30, 2017, at UFC 219 in Las Vegas, Nev. Clomiphene is a Specified Substance in the category of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the WADA Prohibited List.
Oleksiejczuk’s one-year period of ineligibility began on December 30, 2017, the date his positive sample was collected, and is identical in length to the sanction imposed by the Nevada State Athletic Commission (NSAC) on March 13, 2018.
Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing in order to receive credit for time completed under their sanction.
Clomiphene has two purposes. One, many anabolic steroids convert to estrogen, which can lead to a series of unfortunate side effects including Gynecomastia, or b**** t**s; clomiphene can block estrogen from attaching to receptors and prevent them. Second, the use of testosterone-based steroids suppress the body’s natural production of testosterone; clomiphene stimulates the pituitary gland to signal the testicles to restart producing testosterone naturally.
Oleksiejczuk joins Brock Lesnar, Jon Jones, James Mulheron, Nick Roehrick, and Jesse Taylor on the list of fighters who have failed for clomiphene.